| Added by | liaudet-coopman |
|---|---|
| Group name | EquipeELC |
| Item Type | Journal Article |
| Title | [Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France] |
| Creator | MacGrogan et al. |
| Author | Marie-Christine Mathieu |
| Author | Bruno Poulet |
| Author | Frédérique Penault-Llorca |
| Author | Anne Vincent-Salomon |
| Author | Pascal Roger |
| Author | Isabelle Treilleux |
| Author | Alexander Valent |
| Author | Martine Antoine |
| Author | Catherine Bor |
| Author | Eva Brabencova |
| Author | Emmanuelle Charafe-Jauffret |
| Author | Marie-Pierre Chenard |
| Author | Marie-Mélanie Dauplat |
| Author | Paul Delrée |
| Author | Mojgan Devouassoux |
| Author | Maryse Fiche |
| Author | Marie-Eve Fondrevelle |
| Author | Viviana Fridman |
| Author | Christian Garbar |
| Author | Pascal Genin |
| Author | Jean-Pierre Ghnassia |
| Author | Juliette Haudebourg |
| Author | Sophie Laberge-Le Couteulx |
| Author | Delphine Loussouarn |
| Author | Aurélie Maran-Gonzalez |
| Author | Myriam Marcy |
| Author | Patrick Michenet |
| Author | Christine Sagan |
| Author | Martine Trassard |
| Author | Véronique Verriele |
| Author | Laurent Arnould |
| Author | Magali Lacroix-Triki |
| Abstract | Biomarker assessment of breast cancer tumor samples is part of the routine workflow of pathology laboratories. International guidelines have recently been updated, with special regards to the pre-analytical steps that are critical for the quality of immunohistochemical and in situ hybridization procedures, whatever the biomarker analyzed. Fixation and specimen handling protocols must be standardized, validated and carefully tracked. Cooperation and training of the personnel involved in the specimen workflow (e.g. radiologists, surgeons, nurses, technicians and pathologists) are of paramount importance. The GEFPICS' update of the recommendations herein details and comments the different steps of the pre-analytical process. Application of these guidelines and participation to quality insurance programs are mandatory to ensure the correct evaluation of oncotheranostic biomarkers. |
| Publication | Annales De Pathologie |
| Volume | 34 |
| Issue | 5 |
| Pages | 366-372 |
| Date | Oct 2014 |
| Journal Abbr | Ann Pathol |
| Language | fre |
| DOI | 10.1016/j.annpat.2014.08.017 |
| ISSN | 0242-6498 |
| Short Title | [Pre-analytical stage for biomarker assessment in breast cancer |
| Library Catalog | PubMed |
| Extra | PMID: 25439989 |
| Tags | Biomarker, Biomarkers, Tumor, Biomarqueur, Breast Neoplasms, Cancer du sein, clinic, Female, Fixation, Fixative, Fixatives, France, Guidelines, HER2, Histological Techniques, Humans, Immunohistochemistry, Immunohistochimie, In Situ Hybridization, Prognosis, Receptor, ErbB-2, Receptors, Estrogen, Receptors, Progesterone, Receptors, Steroid, Recommandations, Specimen Handling |
| Date Added | 2019/05/29 - 13:15:36 |
| Date Modified | 2019/05/29 - 13:15:48 |
| Notes and Attachments | PubMed entry (Attachment) |
Institut de Recherche en Cancérologie de
